Oscar Health, INC Form 4 insider transactions

Oscar Health director Jeffery H. Boyd has received 3,610 deferred stock units, settled in Class A common stock, as part of his compensation for board service.

Oscar Health director David Plouffe received 1,461 deferred stock units on April 9, 2026, as part of a compensation plan.

Oscar Health CEO Mark T. Bertolini reported transactions involving Class A Common Stock and Performance Restricted Stock Units.

Oscar Health's Chief Financial Officer, Richard Scott Blackley, gifted 75,000 shares of Class A Common Stock to an irrevocable family trust.

Oscar Health President Janet Liang reported the acquisition of restricted stock units and the sale of shares to cover tax obligations.

Oscar Health's CEO, Mark T. Bertolini, was granted 1,596,877 restricted stock units vesting over three years starting March 2027.

Oscar Health's Chief Accounting Officer, Victoria Baltrus, acquired restricted stock units and sold a portion of shares to cover tax obligations.

Oscar Health's Chief Legal Officer, Adam McAnaney, reported the acquisition of restricted stock units and the sale of shares to cover tax withholding obligations.

Oscar Health's President of Technology & CTO, Mario Schlosser, acquired restricted stock units and sold shares to cover tax obligations.

Oscar Health's CFO, Richard Scott Blackley, reported the acquisition of restricted stock units and a pre-planned sale of shares to cover tax obligations.

Oscar Health Director Jeffery H. Boyd acquired 3,106 deferred stock units in lieu of cash retainer payments for board service, increasing his beneficial ownership to 66,248 units.

Oscar Health Director William Gassen elected to receive deferred stock units in lieu of cash for board service, increasing his beneficial ownership.

Oscar Health, Inc. Director David Plouffe elected to receive 1,257 deferred stock units in lieu of cash retainer payments for his board service, aligning his interests further with shareholders.

Oscar Health's President of Technology and CTO, Mario Schlosser, sold 23,038 shares of Class A Common Stock for $17.65 per share under a pre-arranged trading plan.

Oscar Health's President of Technology and CTO, Mario Schlosser, sold 76,962 shares of Class A Common Stock for $17.01 per share under a pre-arranged trading plan.

Oscar Health's President of Technology and CTO, Mario Schlosser, reported the sale of 234,861 shares of Class A common stock in early January 2026, executed under a Rule 10b5-1 trading plan.

Oscar Health's President of Technology & CTO, Mario Schlosser, sold 38,835 shares of Class A Common Stock for approximately $15.00 per share.

Oscar Health's Chief Legal Officer, Adam McAnaney, sold 1,852 shares of Class A Common Stock to cover tax withholding obligations from vested equity awards.

Oscar Health's President of Technology & CTO, Mario Schlosser, sold 23,965 shares of Class A Common Stock to cover tax withholding obligations.

Oscar Health's President, Janet Liang, sold 7,338 shares of Class A Common Stock at a weighted average price of $16.59 per share to cover tax obligations from vested equity awards.

Oscar Health's CFO, Richard Scott Blackley, sold 25,135 shares of Class A Common Stock for tax withholding purposes.

Oscar Health's Chief Accounting Officer, Victoria Baltrus, sold 4,149 shares of Class A Common Stock to cover tax withholding obligations from equity award vesting.

Oscar Health's President of Technology and CTO, Mario Schlosser, reported the exercise of stock options and subsequent sale of Class A common stock to cover costs and tax obligations.

Oscar Health Director William Gassen acquired 1,004 deferred stock units valued at $20.54 each in lieu of cash for his board service.

Oscar Health Director David Plouffe elected to receive 1,034 deferred stock units in lieu of cash for board service, increasing his beneficial ownership.

Oscar Health Director Jeffery H. Boyd acquired 2,555 deferred stock units on October 9, 2025, as part of his compensation election, increasing his total beneficial ownership to 63,142 units.

Oscar Health's President of Technology & CTO, Mario Schlosser, exercised stock options and sold a portion of Class A common stock to cover exercise costs and tax obligations.

Oscar Health's Chief Accounting Officer, Victoria Baltrus, disposed of 6,266 shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

Oscar Health's Chief Financial Officer, Richard Scott Blackley, disposed of 28,166 Class A Common Stock shares to cover tax withholding obligations related to RSU vesting.

Oscar Health's President of Oscar Insurance, Janet Liang, disposed of 7,303 Class A Common Stock shares to cover tax withholding obligations related to RSU vesting.